C Li

ORCID: 0000-0003-4885-936X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Head and Neck Surgical Oncology
  • Systemic Lupus Erythematosus Research
  • Venous Thromboembolism Diagnosis and Management
  • Cytokine Signaling Pathways and Interactions
  • Atrial Fibrillation Management and Outcomes
  • Diagnosis and Treatment of Venous Diseases
  • Bone health and treatments
  • Systemic Sclerosis and Related Diseases
  • Adolescent and Pediatric Healthcare
  • Nasal Surgery and Airway Studies
  • Pregnancy and Medication Impact
  • Cleft Lip and Palate Research
  • Monoclonal and Polyclonal Antibodies Research
  • Ear and Head Tumors
  • Ferroptosis and cancer prognosis
  • Tuberculosis Research and Epidemiology
  • Peripheral Artery Disease Management
  • Cancer, Lipids, and Metabolism
  • Medicinal Plants and Bioactive Compounds
  • Eosinophilic Disorders and Syndromes
  • Mitochondrial Function and Pathology
  • Cancer Immunotherapy and Biomarkers
  • Pulmonary Hypertension Research and Treatments
  • Sarcoidosis and Beryllium Toxicity Research
  • Blood Coagulation and Thrombosis Mechanisms

Capital Medical University
2013-2024

Beijing University of Chinese Medicine
2024

Beijing Tongren Hospital
2021-2023

Beijing Children’s Hospital
2008-2019

Beijing Chest Hospital
1999

The Chinese systemic lupus erythematosus (SLE) treatment and research group (CSTAR) provides major clinical characteristics of SLE in China establishes a platform to provide resources for future basic studies. CSTAR originated as multicentre, consecutive, prospective design. data were collected online from 104 rheumatology centers, which covered 30 provinces China. registered patients required meet four or more the American College Rheumatology (ACR) criteria classification SLE. All centers...

10.1177/0961203313499086 article EN Lupus 2013-08-20

Objectives To estimate the prevalence of pulmonary arterial hypertension (PAH) and risk factors for PAH in patients registered Chinese SLE Treatment Research group (CSTAR) database, first online registry with systemic lupus erythematosus (SLE). Methods A prospective cross-sectional study was conducted using CSTAR registry. Resting transthoracic echocardiography used to artery pressure (PAP); defined as systolic PAP (PASP) ≥40 mmHg. Patients interstitial lung disease, valvular disease or...

10.1177/0961203314527366 article EN Lupus 2014-03-20

The objective of this paper is to assess the role gender on survival rate and causes death organ damage in systemic lupus erythematosus (SLE) patients China from 2009 2015.We conducted a multicenter cohort study analyze differences outcome data between male female SLE patients. A group 1494 who fulfilled 1997 American College Rheumatology classification criteria were enrolled Chinese Systemic Lupus Erythematosus Treatment Research Group (CSTAR) registry April February 2010. All followed up...

10.1177/0961203319839845 article EN Lupus 2019-04-01

Colon adenocarcinoma (COAD) is a frequently occurring and lethal cancer. Cuproptosis an emerging type of cell death, the underlying pathways involved in this process COAD remain poorly understood. Transcriptomic clinical data for patients were collected from The Cancer Genome Atlas (TCGA) Gene Expression Omnibus (GEO) databases. We investigated alterations DNA chromatin cuproptosis-related genes (CRGs) COAD. In order to identify predictive differentially expressed (DEGs) various molecular...

10.3390/ijms252111830 article EN International Journal of Molecular Sciences 2024-11-04

Objective: To evaluate the efficacy of neoadjuvant chemotherapy (NACT) in treatment locally advanced olfactory neuroblastoma (ONB), and to explore factors related NACT. Methods: A total 25 patients with ONB who underwent NACT Beijing TongRen Hospital from April 2017 July 2022 were retrospectively analyzed. There 16 males 9 females, an average age 44.9 years (ranged 26-72 years). 22 cases Kadish stage C 3 D. After multiple disciplinary team(MDT) discussion, all treated sequentially...

10.3760/cma.j.cn115330-20230115-00026 article EN PubMed 2023-05-07

Purpose: The objective was to determine the effectiveness and safety of paclitaxel-coated balloon angioplasty in hemodialysis patients with diabetic nephropathy (DN). Materials Methods: outcomes end-stage renal disease (ESRD) peripheral artery (PAD) treated drug-coated (DCB) were retrospectively evaluated. clinical improvement Rutherford classification target lesion revascularization (TLR). Safety all-cause mortality amputation. Results: Ninety-seven DCB between December 2018 2020. 87...

10.1177/15266028231197602 article EN Journal of Endovascular Therapy 2023-09-07

Results 42 patients were diagnosed MAS with SOJIA from 159 cases. The duration prior to is 11 months. High fever, hepatosplenomegaly, pancytopenia, liver dysfunction in all Bleeding was 12. 45% has had CNS dysfunction. 24% ARDS. 2 suffered renal damage. lab.tests revealed elevated live enzymes and ferritin, decreased value of ESR, album, CBC fibrinogen all. Bone marrow examination supported the diagnosis definite haemophagocytosis Lymph node biopsy done for one case found out it filled...

10.1186/1546-0096-6-s1-p33 article EN cc-by Pediatric Rheumatology 2008-09-01

Objective: To summarize the follow-up outcomes of frontal drill out procedures (draf Ⅱb, extended draf Ⅱb and Ⅲ) using mucosal flaps, discuss surgical indications different flaps their potential benefits to opening neo-ostium. Methods: A total 48 patients with chronic rhinosinusitis or mucoceles treated by Ⅲ between 2013 2019 in Beijing TongRen Hospital were enrolled this study. Twenty-four who considered as flap group (including 19 males 5 females, aging from 71 years), other 24 didn't have...

10.3760/cma.j.cn115330-20211215-00797 article EN PubMed 2022-08-07

To study the efficacy and patient comfort of absorbable hemostatic powder after endoscopic sinus surgery (ESS).

10.3760/cma.j.cn115330-20200814-00673 article EN Zhonghua er-bi-yanhou-tou-jing waike zazhi 2021-02-03
Coming Soon ...